KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Short-Term Debt issuances (2016 - 2025)

Humana (HUM) has disclosed Short-Term Debt issuances for 16 consecutive years, with $28.0 million as the latest value for Q2 2025.

  • On a quarterly basis, Short-Term Debt issuances changed N/A to $28.0 million in Q2 2025 year-over-year; TTM through Sep 2025 was -$182.0 million, a N/A change, with the full-year FY2024 number at $50.0 million, down 9.09% from a year prior.
  • Short-Term Debt issuances was $28.0 million for Q2 2025 at Humana, up from -$33.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $284.0 million in Q4 2022 to a low of -$725.0 million in Q3 2022.
  • A 4-year average of -$50.2 million and a median of -$9.0 million in 2022 define the central range for Short-Term Debt issuances.
  • Peak YoY movement for Short-Term Debt issuances: soared 251.87% in 2022, then crashed 1866.67% in 2023.
  • Humana's Short-Term Debt issuances stood at -$187.0 million in 2021, then skyrocketed by 251.87% to $284.0 million in 2022, then tumbled by 162.32% to -$177.0 million in 2023, then skyrocketed by 115.82% to $28.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Short-Term Debt issuances are $28.0 million (Q2 2025), -$33.0 million (Q1 2025), and -$177.0 million (Q1 2023).